- Trials with a EudraCT protocol (1,000)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (26)
1,000 result(s) found for: Estrogen.
Displaying page 1 of 50.
EudraCT Number: 2004-000053-34 | Sponsor Protocol Number: 0473081 | Start Date*: 2004-07-28 | |||||||||||
Sponsor Name:Orion Corporation, Orion Pharma, Orionintie, | |||||||||||||
Full Title: Comparison of continuous combined estrogen-progestin regimen in alleviation of estrogen deficiency symptoms of postmenopausal women. A randomized, double-blind, fixed dose, multicentre phase IIIb ... | |||||||||||||
Medical condition: Postmenopausal estrogen replacement regimen is the therapy of choice for the alleviation of climacteric symptoms. During the past few years, continuous-combined hormone replacement therapy (HRT) ... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004864-37 | Sponsor Protocol Number: ASP-OP3-1 | Start Date*: 2018-05-16 | |||||||||||
Sponsor Name:Aspen Global Incorporated | |||||||||||||
Full Title: A Multinational, Phase 3, Double-blind, Placebo-Controlled, Randomized Study to Assess the Efficacy and Safety of Ovestin in the Treatment of Symptoms of Vulvar and Vaginal Atrophy in Postmenopausa... | |||||||||||||
Medical condition: Vulvovaginal atrophy associated with menopause | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: BG (Prematurely Ended) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-004008-71 | Sponsor Protocol Number: ELDORADO | Start Date*: 2017-01-19 |
Sponsor Name:Erasmus MC Cancer Institute | ||
Full Title: The effect of curcumin and piperine on the pharmacokinetics of tamoxifen in patients with estrogen receptor positive breast cancer ‘the ELDORADO study’ | ||
Medical condition: Estrogen receptor positive breast cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-001234-34 | Sponsor Protocol Number: 118 | Start Date*: 2020-04-08 | ||||||||||||||||
Sponsor Name:HUS Syöpäkeskus | ||||||||||||||||||
Full Title: Effects of Vaginal Estrogens on Serum Estradiol Levels in Postmenopausal Women with Breast Cancer Taking an Aromatase Inhibitor. | ||||||||||||||||||
Medical condition: Breast cancer, postmenopausal atrophic vaginitis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Elderly | Gender: Female | |||||||||||||||||
Trial protocol: FI (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-000696-39 | Sponsor Protocol Number: HNF1595-21 | Start Date*: 2023-02-21 |
Sponsor Name:Helse-Nord | ||
Full Title: Estrogen replacement therapy (ERT) for treatment of adolescent anorexia nervosa – An open label study | ||
Medical condition: Anorexia nervosa | ||
Disease: | ||
Population Age: Adolescents, Under 18 | Gender: Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-005685-12 | Sponsor Protocol Number: 20070724 | Start Date*: 2008-10-09 |
Sponsor Name:Universitätsklinik für Psychiatrie und Psychotherapie, Klin. Abteilung f. Biologische Psychiatrie | ||
Full Title: The influence of hormone replacement therapy on the cerebral serotonin-1A receptor distribution and mood in postmenopausal women | ||
Medical condition: Healthy postmenopausal women receiving standard hormone replacement therapy are measured using positron emission tomography to investigate the effects of hormones on the cerebral serotonin-1A recep... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-000073-23 | Sponsor Protocol Number: CRAD001YIC04 | Start Date*: 2012-05-18 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: An open-label, multi-center, expanded access study for postmenopausal women with estrogen receptor positive locally advanced or metastatic breast cancer who have progressed following prior endocrin... | |||||||||||||
Medical condition: Estrogen receptor positive locally advanced or metastatic breast cancer in postmenopausal women | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: AT (Completed) NL (Completed) SE (Completed) NO (Completed) ES (Completed) DK (Completed) FI (Completed) BE (Completed) CZ (Prematurely Ended) IT (Completed) HU (Completed) IE (Completed) SK (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002337-22 | Sponsor Protocol Number: AEZS-130-052 | Start Date*: 2015-12-08 |
Sponsor Name:Aeterna Zentaris GmbH | ||
Full Title: Confirmatory validation of oral macimorelin as a Growth Hormone (GH) Stimulation Test (ST) for the diagnosis of Adult Growth Hormone Deficiency (AGHD) in comparison with the Insulin Tolerance Test ... | ||
Medical condition: Diagnosis of Adult Growth Hormone Deficiency (AGHD) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) AT (Completed) DE (Completed) PL (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-003981-42 | Sponsor Protocol Number: 2012.2708 | Start Date*: 2014-10-20 |
Sponsor Name:University Medical Center Groningen [...] | ||
Full Title: Estrogen receptor and androgen receptor imaging in metastatic breast cancer patients | ||
Medical condition: Estrogen receptor positive metastatic breast cancer patients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-003065-17 | Sponsor Protocol Number: CRAD001Y24135 | Start Date*: 2013-05-16 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: An open-label, phase II, single-arm study of everolimus in combination with letrozole in the treatment of postmenopausal women with estrogen receptor positive HER2 negative metastatic or locally ad... | |||||||||||||
Medical condition: Estrogen receptor positive metastatic breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) ES (Completed) FR (Completed) NL (Completed) PT (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-003960-22 | Sponsor Protocol Number: WOO2 | Start Date*: 2021-03-15 | |||||||||||
Sponsor Name:Medical University of Innsbruck | |||||||||||||
Full Title: Prospective Window of opportunity trial of 3 weeks neoadjuvant Anastrozole in Postmenopausal Women with Estrogen receptor positive (ER+) Breast Cancer | |||||||||||||
Medical condition: (ER+) Breast Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001716-38 | Sponsor Protocol Number: 1404-BIO-019-MF | Start Date*: 2017-04-26 |
Sponsor Name:IVI BILBAO | ||
Full Title: Influence instillation plasma rich in growth factors in endometrial cavity | ||
Medical condition: Women receiving cycle of oocytes outside or embryos (own / others), in the treatment of substituted cycle type. Less than 5 mm Endometrio despite 10 days with standard doses of estrogen therapy (6... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2012-003757-28 | Sponsor Protocol Number: CRAD001Y2201 | Start Date*: 2013-02-20 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A three-arm, randomized, open label, phase II study of everolimus in combination with exemestane versus everolimus alone versus capecitabine in the treatment of postmenopausal women with estrogen r... | |||||||||||||
Medical condition: Estrogen receptor positive locally advanced or metastatic breast cancer in postmenopausal women | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: BE (Completed) SE (Completed) GB (Completed) IE (Completed) DK (Completed) ES (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002326-39 | Sponsor Protocol Number: 1-10-72-57-15 | Start Date*: 2015-08-19 | |||||||||||
Sponsor Name:Gynecology Department,Herning Hospital [...] | |||||||||||||
Full Title: The influence of fat intake, estrogen, age, and gender on postprandial lipds and glucose | |||||||||||||
Medical condition: Healthy volunteers | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-001624-17 | Sponsor Protocol Number: 210321 | Start Date*: 2021-07-21 |
Sponsor Name:Karolinska University Hospital | ||
Full Title: Safety of oral micronized progesterone versus norethisterone acetate in continuous combination with oral estrogen as menopausal hormone therapy – a double-blind randomized study- PROBES study (Prog... | ||
Medical condition: Climacteric symptoms | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-001179-39 | Sponsor Protocol Number: 2005108 | Start Date*: 2006-10-11 | |||||||||||
Sponsor Name:Procter & Gamble Pharmaceuticals | |||||||||||||
Full Title: A Randomised, Double-Blind, Placebo-Controlled, Parallel-group, Multicentre, 24 week Study to Evaluate the Efficacy and Safety of Transdermal Testosterone (300 mcg/day) in Naturally Menopausal Wome... | |||||||||||||
Medical condition: Hypoactive sexual desire disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000693-30 | Sponsor Protocol Number: 56UCS2017 | Start Date*: 2019-11-25 | |||||||||||
Sponsor Name:ENTE OSPEDALIERO OSPEDALI GALLIERA | |||||||||||||
Full Title: EXemestane in Progesterone and/or Estrogen receptor positive epithelial ovarian cancer. A Randomized phase III Trial, EXPERT. | |||||||||||||
Medical condition: Women with confirmed high grade serous or endometrial epithelial ovarian cancer. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000106-19 | Sponsor Protocol Number: GO29689 | Start Date*: 2015-12-10 | |||||||||||
Sponsor Name:Genentech, Inc | |||||||||||||
Full Title: A PHASE II, OPEN-LABEL, RANDOMIZED STUDY OF GDC-0810 VERSUS FULVESTRANT IN POSTMENOPAUSAL WOMEN WITH ADVANCED OR METASTATIC ER+/HER2- BREAST CANCER RESISTANT TO AROMATASE INHIBITOR THERAPY | |||||||||||||
Medical condition: Advanced or Metastatic ER+/HER2- Breast Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-001064-27 | Sponsor Protocol Number: s55283 | Start Date*: 2013-06-25 |
Sponsor Name:University Hospitals Leuven | ||
Full Title: Placebo-controlled trial with vitamin D to prevent worsening/relieve aromatase inhibitor-induced musculoskeletal symptoms in breast cancer patients | ||
Medical condition: aromatase inhibitor-induced musculoskeletal symptoms in postmenopausal breast cancer patients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: BE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2021-005081-17 | Sponsor Protocol Number: ARV-471-BC-201 | Start Date*: 2023-01-20 | ||||||||||||||||
Sponsor Name:Arvinas Estrogen Receptor, Inc. (Arvinas) | ||||||||||||||||||
Full Title: An Open-Label, Randomized, Non-Comparative Phase 2 Study of ARV-471 or Anastrozole in Post-Menopausal Women With ER+/HER2– Breast Cancer in the Neoadjuvant Setting | ||||||||||||||||||
Medical condition: Post-menopausal women with ER+ HER2– breast cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: DE (Ongoing) ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.